Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. by Niraj K. Nirala (424266)

“…Comparison of different FOXO in liver tissue of wild type (+/+) and CERT heterozygous (+/−) mice shows significant decrease in their transcript levels. (C). Comparison of glycolytic genes in skeletal muscle from wild type (+/+) and CERT heterozygous (+/−) mice shows greater than 5 fold increase in transcript levels of phosphoglycerate mutase and pyruvate kinase and 1.8 fold increase in hexokinase. …”

CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

“…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”

ERG amplitude and peak latency gradually decreased after the continuous dark exposure. by Dake Li (2940168)

Cell-penetrating 15mer peptides decrease the proliferation and viability of cancer cells. by Pavan Kumar Puvvula (10495853)

Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> heart. by Craig Bolte (299486)

“…Capillary density was decreased in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> hearts at P11 (A–B, I), while coronary vessel formation was not altered (C–D). …”

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Transplantation of Exendin-4 pretreated ADSCs decrease apoptosis, fibrosis, and promote angiogenesis. by Jianfeng Liu (122580)

Terpenoids decrease single-channel activity of L-AChRs elicited by ACh. by Guillermina Hernando (553795)

Thimerosal decreases the expression of survivin via the PI3K/Akt pathway. by Wen-Xue Li (189757)

Patterns of <i>CMJ101C</i> mRNA induced expression by heat shock. by Nobuko Sumiya (648113)

Subjects:

Deletion of STX1B decreases frequency of mEPSCs and mIPSCs. by Tatsuya Mishima (529071)

Effect of i.c.v. infusion of rrIL-1ra on poly I:C-induced decrease in spontaneous activity. by Masanori Yamato (534076)

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)

Enforced miR-509 expression in decreased proportion of cells in S-phase, induced apoptosis and activated caspase-3/7. by Yee Sun Tan (176098)

The acute application of dexamethasone decreases glutamate release from excitatory neurons of the amygdala. by Guang-Yan Wang (3352889)

Akt inhibition by DEBC decreases membrane lipid rafts defined by density floatation. by Fumin Dong (664375)

Transient silencing of APIP decreases the growth of the HeLa cells in MTA medium. by Camille Mary (291547)

pT120 β-catenin is significantly decreased in TGN of prostate cancer samples. by Cheng Du (19060)

Inhibition of SNAI2 expression decreases the sensitivity to chemotherapy drugs of HCC cells. by Xin-Yu Zhao (3228756)